Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
IT
EN
☰
Competenze e Professionalità
|
UNIFIND
-
Competenze e Professionalità
unime.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
☰
Pubblicazioni
BRITISH JOURNAL OF HAEMATOLOGY
Rivista
Codice:
E025360
ISSN:
0007-1048
Dati Generali
Dati Generali
Pubblicazioni (29)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
Articolo
AN UNUSUAL PRESENTATION OF SCHISTOSOMIASIS
Articolo
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report
Articolo
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias
Articolo
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report
Articolo
Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab
Articolo
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.
Articolo
HIF1α and Glut1 receptor in transfused and untransfused thalassemic patients
Articolo
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Articolo
Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients
Articolo
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.
Articolo
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
Articolo
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma
Articolo
Multidrug resistance mechanisms in chronic lymphocytic leukaemia
Articolo
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia
Articolo
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib
Articolo
RAPID REVERSION OF EOSINOPHILIC GASTROENTERITIS AFTER TARGET THERAPY WITH IMATINIB
Articolo
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
Articolo
Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapy
Articolo
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study
Articolo
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response
Articolo
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response.
Articolo
Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma
Articolo
Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker
Articolo
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF
Articolo
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF.
Articolo
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Articolo
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database.
Articolo
Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
